Stephen Liu, MD

Provider is directly employed by MedStar Health

Dr. Stephen Liu, MD, is the division chief of Hematology Oncology at MedStar Georgetown University Hospital, part of the MedStar Georgetown Cancer Institute. Dr. Liu is also a faculty member, investigator, and an active researcher through the hospital’s research engine, Georgetown Lombardi Comprehensive Cancer, the only NCI-designated comprehensive cancer center in the region providing access to breakthrough cancer therapies and clinical trials.

Dr. Liu graduated cum laude from Johns Hopkins University before receiving his MD at the University of Maryland. He completed Internal Medicine training at the University of Pennsylvania and completed a fellowship in Hematology and Oncology at the University of Southern California, after which he received further specialized training in genomic medicine at the Translational Genomics Research Institute (TGen). Dr. Liu has been part of the Thoracic Oncology section and the Experimental Therapeutics Program of Georgetown University since 2013. He is a board-certified medical oncologist with expertise in lung cancer and drug development. 
 
Dr. Liu has a research focus on the development of novel therapeutic agents and innovative combinations for the treatment of advanced thoracic malignancies. He leads the Thoracic Oncology section and the Phase I Developmental Therapeutics group. His work has been published in journals such as the New England Journal of Medicine, Journal of Clinical Oncology, Journal of Thoracic Oncology, Lancet Oncology, Cancer Discovery, and Clinical Cancer Research. He is actively involved in post-graduate education and has been awarded multiple teaching awards for his efforts. In addition to leading national and global clinical trials for the treatment of lung cancer, Dr. Liu is also the co-host for the official IASLC (International Association for the Study of Lung Cancer) podcast, Lung Cancer Considered.

Dr. Liu's philosophy of care
"I subscribe to MedStar Georgetown University Hospital's mission - cura personalis - caring for the whole person - and I am an advocate for my patients. I stress the importance of open communication between physicians and patients and strive to provide my patients with the most advanced care available. I strongly believe that all patients deserve the opportunity to benefit from the latest cancer research advances, including genomic testing which is an essential part of treatment decisions. I am also committed to conducting research that will contribute to our understanding of cancer and helping future patients. Clinical trials are often the best treatment option in lung cancer and we strive to have the most promising agents available for our patients."